SCHEMBL13197850

SCHEMBL13197850

CCCS(=O)(=O)O/N=C(\C#N)c1cc(C)cc(C)c1

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL36729 0.86 KMT2A (0.33)
SCHEMBL297765 0.86 KMT2A (0.33)
SCHEMBL16501295 0.82 TPMT (0.34)
SCHEMBL2702572 0.82 PLA2G7 (0.40)
SCHEMBL2702574 0.82 PLA2G7 (0.40)
SCHEMBL4825418 0.78 RECQL (0.39) KDM4E
SCHEMBL4825409 0.78 RECQL (0.39) KDM4E
SCHEMBL7786403 0.78 ALDH1A1 (0.42)
SCHEMBL7781772 0.77 MAPT (0.36) KDM4E
SCHEMBL18819681 0.77 PARP10 (0.40) KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210147352-A1 SULFONIUM SALT, PHOTOACID GENERATOR, CURABLE COMPOSITION, AND RESIST COMPOSITION SAN-APRO LTD. (JP) 2021-05-20 US disclosed
EP-3050875-B1 NOVEL IMIDAZOLE DERIVATIVE AND THERAPEUTICAL USE THEREOF UNIV YONSEI IACF (KR) 2019-03-13 EP disclosed
WO-2014061062-A1 SULFONIUM SALT, PHOTOACID GENERATOR, CURABLE COMPOSITION, AND RESIST COMPOSITION サンアプロ株式会社 (JP) 2014-04-24 WO disclosed
US-20110300482-A1 SULFONIUM SALT, PHOTO-ACID GENERATOR, AND PHOTOSENSITIVE RESIN COMPOSITION SAN-APRO, LTD (JP) 2011-12-08 US disclosed
US-20110300482-A1 SULFONIUM SALT, PHOTO-ACID GENERATOR, AND PHOTOSENSITIVE RESIN COMPOSITION SAN-APRO, LTD (JP) 2011-12-08 US disclosed
WO-2010095385-A1 SULFONIUM SALT, PHOTO-ACID GENERATOR, AND PHOTOSENSITIVE RESIN COMPOSITION サンアプロ株式会社 (JP) 2010-08-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210147352-A1 SULFONIUM SALT, PHOTOACID GENERATOR, CURABLE COMPOSITION, AND RESIST COMPOSITION H1-0, SPIN1, IK KDM4E 2090/4885
US-20110300482-A1 SULFONIUM SALT, PHOTO-ACID GENERATOR, AND PHOTOSENSITIVE RESIN COMPOSITION ASIC1, H1-0, IK KDM4E 960/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.